Keywords: philippines, appro, sciclone, zadaxin, usa-based, pharmaceuticals, received

Philippines Appro For SciClone's Zadaxin

Article | 01 July 1996

Print This

USA-based SciClone Pharmaceuticals has received approval to market its Zadaxin (thymosin alpha 1) as a treatment for chronic hepatitis B from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in